sellWeak10b5-1 plan
Stephen K. Brannan sold $2.0M of KRTX
Chief Medical Officer at Karuna Therapeutics, Inc.. 10,000 shares at an average of $202.37, traded Dec 8, 2023, filed Dec 12, 2023.
Warning score
10Value
$2.0M
10,000 shares
Holdings after
36,150
-22% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- +25Trade size$2.0M at market
- +5Share of holdings soldSold 22% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-23-069766, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Dec 8, 2023 | MOption exercise Common Stock10b5-1 | +2,500 | $5.45 | $14k | 36,150 | Dec 12, 2023 |
| Dec 8, 2023 | MOption exercise Common Stock10b5-1 | +10,000 | $131.64 | $1.3M | 46,150 | Dec 12, 2023 |
| Dec 8, 2023 | SOpen-market sale Common Stock10b5-1 | -1,565 | $200.11 | $313k | 44,585 | Dec 12, 2023 |
| Dec 8, 2023 | SOpen-market sale Common Stock10b5-1 | -2,116 | $201.73 | $427k | 42,469 | Dec 12, 2023 |
| Dec 8, 2023 | SOpen-market sale Common Stock10b5-1 | -3,969 | $202.74 | $805k | 38,500 | Dec 12, 2023 |
| Dec 8, 2023 | SOpen-market sale Common Stock10b5-1 | -2,251 | $203.80 | $459k | 36,249 | Dec 12, 2023 |
| Dec 8, 2023 | SOpen-market sale Common Stock10b5-1 | -99 | $204.18 | $20k | 36,150 | Dec 12, 2023 |
| Dec 8, 2023 | MOption exercise Option (right to buy)derivative10b5-1 | -2,500 | $0.00 | $0 | 12,177 | Dec 12, 2023 |
| Dec 8, 2023 | MOption exercise Option (right to buy)derivative10b5-1 | -10,000 | $0.00 | $0 | 21,350 | Dec 12, 2023 |
Related signals
Other insiders at Karuna Therapeutics, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 10Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $1.6M 5,000 shares | -11% | |
| 10Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $1.6M 5,000 shares | -11% | |
| 15Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $4.8M 15,000 shares | -28% | |
| 8Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $889k 5,000 shares | -13% | |
| 15Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $1.0M 5,000 shares | -27% | |
| 15Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $1.1M 5,000 shares | -25% | |
| 15Weak | Karuna Therapeutics, Inc. | Stephen K. Brannan Chief Medical Officer | $1.0M 5,000 shares | -25% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.